Optimi Health Corp. launches an Ibogaine Initiative to meet demand for pharmaceutical-grade ibogaine and expand its global strategy in psychedelic therapies, aligning with U.S. regulatory changes.
Optimi Health Corp. launches an Ibogaine Initiative to meet demand for pharmaceutical-grade ibogaine and expand its global strategy in psychedelic therapies, aligning with U.S. regulatory changes.